Imran Liaquat

NHS Lothian, Scotland

I have been a Consultant Neurosurgeon at the Western General Hospital in Edinburgh since 2013 and have led the Adult Neuro-oncology service since appointment. I set-up the Low Grade Glioma service with colleagues in 2015 and have an interest in using new technology, functional MRI and evolving surgical techniques to achieve maximal safe resection in Low Grade Glioma Patients.

I have recently been appointed the Lead Clinician for the Scottish Adult Neuro-oncology Network and recently organised the British Neuro-oncology Society Meeting in Edinburgh.

In addition to my Brain tumour interests, I also participate in the management of General Neurosurgical and Spinal diseases.

dont miss

Optimising Surgical Resection in Low Grade Glioma Patients

This seminar will explore current advances in surgical techniques and technology that can enhance the extent of resection in Low Grade Gliomas, such as Awake Craniotomy and Intraoperative Neurophysiological Monitoring. The seminar will also explore the role of Functional MRI Imaging and Neuro-navigation, as well as Intraoperative MRI and Ultrasound, in achieving maximal safe resection.

EVEN MORE SEMINARS

  • Laura Allington: Speaking at the Oncology Convention

    Laura Allington
    University College London Hospitals NHS Foundation Trust

    Operational challenges of planning a new NHS high energy proton service.

  • Philip Beer MRCP, FRCPath, PhD: Speaking at the Oncology Convention

    Philip Beer MRCP, FRCPath, PhD
    ONCODNA S.A

    The evolution of oncology therapeutics in the genomic era.

  • Prof Adam Waldman: Speaking at the Oncology Convention

    Prof Adam Waldman
    MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

    Biomarkers in Adult Glioma

  • Michiel van den Brekel: Speaking at the Oncology Convention

    Michiel van den Brekel
    The Netherlands Cancer Institute

    Vocal and pulmonary rehabilitation after total laryngectomy

  • Michael Schreiber: Speaking at the Oncology Convention

    Michael Schreiber
    Brain Tumor Foundation, Chairman

    Brain Tumors - Innovation, support and advocacy